Clinical Trial Update: Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 trial evaluating the combination of bortezomib, mitoxantrone, etoposide, and cytarabine in adults with relapsed o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Bortezomib (bortezomib)
• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 1 | Status: COMPLETED